Two sample MR report
3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) levels against Rheumatoid arthritis || id:ebi-a-GCST90018910
Date: 08 November, 2026
Results from two sample MR:
| method |
nsnp |
b |
se |
pval |
| MR Egger |
3 |
-0.0465140 |
0.1757084 |
0.8352514 |
| Weighted median |
3 |
-0.1186725 |
0.0686797 |
0.0840039 |
| Inverse variance weighted |
3 |
-0.1301702 |
0.0651232 |
0.0456268 |
| Simple mode |
3 |
-0.1065686 |
0.0904694 |
0.3599952 |
| Weighted mode |
3 |
-0.1155067 |
0.0774622 |
0.2744259 |
Heterogeneity tests
| method |
Q |
Q_df |
Q_pval |
| MR Egger |
0.4267713 |
1 |
0.5135775 |
| Inverse variance weighted |
0.6895479 |
2 |
0.7083805 |
Test for directional horizontal pleiotropy
| egger_intercept |
se |
pval |
| -0.0214296 |
0.0418043 |
0.6984393 |
Test that the exposure is upstream of the outcome
| snp_r2.exposure |
snp_r2.outcome |
correct_causal_direction |
steiger_pval |
| 0.0004444 |
0 |
TRUE |
0.0582658 |
Note - R^2 values are approximate
Forest plot of single SNP MR

Comparison of results using different MR methods

Funnel plot

Leave-one-out sensitivity analysis
